EXACERBATIONS OF THE USE OF SELENIUM-CONTAINING DRUGS IN PREGNANT WOMEN IN THE PREVENTION OF FETOPLACENTAR DEFICIENCY

dc.contributor.authorJalilova Dildora Murotovna
dc.date.accessioned2025-12-29T17:57:33Z
dc.date.issued2025-02-14
dc.description.abstractPre-term childbirth remains one of the most pressing problems of modern obstetrics, and this is about 11% of the world.Preterm labor is said to stop prematurely during the gestational period from the 22nd week to the 37th week of pregnancy.FPY , which occurs with a violation of the placenta process and leads to the underdevelopment of the placenta, is one of the causes of premature birth. Therefore, at present, it is very important to develop modern diagnostic methods and apply preventive measures, which will allow you to identify pathological changes in the fetoplacentar complex at the initial, pre-clinical stage of the disease.
dc.formatapplication/pdf
dc.identifier.urihttps://webofjournals.com/index.php/5/article/view/3279
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/24408
dc.language.isoeng
dc.publisherWeb of Journals Publishing
dc.relationhttps://webofjournals.com/index.php/5/article/view/3279/3237
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWeb of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 3 No. 2 (2025): WOM; 261-264
dc.source2938-3765
dc.titleEXACERBATIONS OF THE USE OF SELENIUM-CONTAINING DRUGS IN PREGNANT WOMEN IN THE PREVENTION OF FETOPLACENTAR DEFICIENCY
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
murotovna_2025_exacerbations_of_the_use_of_selenium-con.pdf
item.page.filesection.size
308.63 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections